Molecular Detection of Mycobacterium tuberculosis in the Indigenous Population of Tharparkar, Sindh, Pakistan. Using GeneXpert Assay: Age and Gender Stratified Analysis
GeneXpert Detection of M. tuberculosis in Tharparkar
Keywords:
Gene Xpert MTB/RIF, Mycobacterium tuberculosis, Multi-Drug-Resistant TB, Pulmonary TB, Sputum analysisAbstract
Background: Mycobacterium tuberculosis (MTB) the causative agent of Tuberculosis (TB), spreads through air from infected persons via coughing, sneezing etc. It affects various body organs such as kidneys, brain, spine but in majority of cases it affects lungs and causes pulmonary TB. The distribution of the Pulmonary tuberculosis burden across Pakistan is diverse, with incidence rates ranging from 110 cases per 100,000 to 462 cases per 100,000 inhabitants. Given that Tharparkar is a rural and underdeveloped area, the TB burden is underreported. The current paper evaluates the burden of TB cases in the indigenous population of Tharparkar region of Province Sindh with age and gender wise stratified analysis.
Methods: A total of 1,099 sputum samples from clinically and radiologically suspected TB patients were tested for MTB and rifampicin resistance using the GeneXpert/RIF assay. Data was analyzed using IBM SPSS Statistics version 20, applying chi-square tests and odds ratios (95% CI) to assess differences in MTB positivity across age groups and genders.
Results: Of the 1,099 samples, 198 (18%) were MTB positive. Notably, no case of MDR-TB was detected. MTB prevalence was slightly higher in males (n=133, 18.9%, median age: 40) than in females (n=65, 16.4%, median age: 35). The highest positivity (n=11, 25.6%) was observed in the 71–80 age group. Gender-specific trends showed peak prevalence in males aged 71–80 (n=9, 33%) and in females aged 11–20 (n=10, 27%, mean age: 18.08 years). Differences in prevalence between genders exceeded 60% in the 41–50 and 71–80 age groups, though not statistically significant (p-values = 0.083 and 0.130).
Conclusion: Tharparkar data indicates a significantly lower prevalence, approximately 61.5% lesser, than in KPK and FATA, earlier onset in females and absence of MDR-TB, indicating region’s unique environmental or sociocultural factors need further investigation.
References
Mousavi-Sagharchi SMA, Ghorbani A, Meskini M, Siadat SD. Historical examination of tuberculosis; from ancient affliction to modern challenges. J Infect Public Health. 2025;18(3):102649.
DOI: https://doi.org/10.1016/j.jiph.2024.102649
Tereza Kasaeva (WHO Report). Global tuberculosis report 2024. WHO Global Tuberculosis Programme; 2024. Available from: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024
Kadhiravan T, Sharma SK. Medical management of genitourinary tuberculosis. Indian J Urol. 2008;24(4):362.
DOI: https://doi.org/10.4103/0970-1591.42619
Hamada Y, Getahun H, Tadesse BT, Ford N. HIV-associated tuberculosis. Int J STD AIDS. 2021;32:780–90.
DOI: https://doi.org/10.1177/0956462421992257
Sajjad Ahmad SAAU, AS. Evaluation of GeneXpert MTB/RIF Assay for Detection of Pulmonary Tuberculosis on Sputum Samples. J Coll Physicians Surg Pak. 2019;29(1):66–9.
DOI: https://doi.org/10.29271/jcpsp.2019.01.66
Haas AL, Ma A, Pham J, Verma P, Malhotra U, Church EC, et al. Limitations of the MTB/RIF Assay: An Xpert Review of 4 Clinical Cases. Open Forum Infect Dis. 2025;12(4).
DOI: https://doi.org/10.1093/ofid/ofaf132
Sailo CV, Lalremruata R, Sanga Z, Fela V, Kharkongor F, Chhakchhuak Z, et al. Distribution and frequency of common mutations in rpoB gene of Mycobacterium tuberculosis detected by Xpert MTB/RIF. J Clin Tuberc Other Mycobact Dis. 2022;29:100342.
DOI: https://doi.org/10.1016/j.jctube.2022.100342
WHO Press. Rapid Implementation of the Xpert MTB/RIF Diagnostic Test: Technical and Operational “How-to.” WHO Library Catalogue; 2011. Available from: http://www.who.int/about/licensing/copyright_form/en/index.html
National TB Control Program, The Islamic Republic of Pakistan. National TB Control Program 2020–23. 2020. Available from: https://ntp.gov.pk/wp-content/uploads/2020/04/TB%20NSP%20-2020-2023
Mengal MZ, Ali H, Asmat R, Naeem M, Abbas F, Samad A, et al. Detection of mutations in rpoB gene using GeneXpert MTB/RIF in clinical specimens from Quetta, Pakistan. Pak J Zool. 2020;53(1):1–7.
DOI: https://doi.org/10.17582/journal.pjz/20190522060512
Hammad M, Sharjeel M, Fazal I, Aziz A, Shahid F, Iqbal M. Pattern of drug resistance among patients presenting with relapse of pulmonary tuberculosis. Pak Armed Forces Med J. 2024;74(2):362–6.
DOI: https://doi.org/10.51253/pafmj.v74i2.7772
Khursheed N, Asif S, Bano S, Ali MM, Adnan F. Susceptibility pattern of Mycobacterium tuberculosis at Indus Hospital and Health Network, Karachi. Pak J Med Sci. 2022;38:399–404.
DOI: https://doi.org/10.12669/pjms.38.ICON-2022.5778
Baig S. MDR TB – The lethal sound of silent mutations. J Coll Physicians Surg Pak. 2024;34:867–8.
DOI: https://doi.org/10.29271/jcpsp.2024.08.867
Laghari M, Sulaiman SAS, Khan AH, Memon N. A prospective study of socio-demographic, clinical characteristics and treatment outcomes of children with tuberculosis in Sindh, Pakistan. BMC Infect Dis. 2019;19(1).
DOI: https://doi.org/10.1186/s12879-019-3702-3
Sagheer N, SSNSSAAM. Examining tuberculosis cases using sputum testing across two tehsils of district Okara, Punjab, Pakistan (2019–2023). Azerbaijan Pharm Pharmacother J. 2024;4(23):31–40.
DOI: https://doi.org/10.61336/appj/24-04-03
Sadaf R, Munir T, Farrukh S, Abbasi S. Prevalence of latent tuberculosis infection in healthcare workers in tertiary care hospitals of Pakistan. Pak J Med Sci. 2020;36(2):198–202.
DOI: https://doi.org/10.12669/pjms.36.2.936
Jabeen C, Mushtaq MH, Khan JA, Umbreen G, Saeed MS, Sadiq S, et al. Burden and factors associated with occupational tuberculosis infection among high-risk workers in Lahore District, Pakistan. J Infect Dev Ctries. 2024;18(7):1041–9.
DOI: https://doi.org/10.3855/jidc.17965
Li K, Li L. Correlation between Xpert MTB/RIF results and rpoB mutations within probe-targeted regions in Mycobacterium tuberculosis isolates from Sichuan Basin. Infect Drug Resist. 2025;18:5161–71.
DOI: https://doi.org/10.2147/IDR.S541544
Memon A, Ali Laghari Z, Ali Samo A. Factors associated with prevalence of stunting and thinness among adolescents of Tharparkar, Sindh, Pakistan: A community-based study. PLoS One. 2025;20(4).
DOI: https://doi.org/10.1371/journal.pone.0318055
Schwalb A, Samad Z, Yaqoob A, Fatima R, Houben RMGJ. Subnational tuberculosis burden estimation for Pakistan. PLOS Glob Public Health. 2024;4(9).
DOI: https://doi.org/10.1371/journal.pgph.0003653
Jawad M, Bilal A, Khan S, Rizwan M, Arshad M. Prevalence and awareness survey of tuberculosis in suspected population of Bajaur Agency, Pakistan. Pak J Health Sci. 2023;4(6):56–61.
DOI: https://doi.org/10.54393/pjhs.v4i06.793
Ali S, Khan MT, Khan AS, Mohammad N, Khan MM, Ahmad S, et al. Prevalence of multidrug-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan. Pol J Microbiol. 2020;69(2):133–7.
DOI: https://doi.org/10.33073/pjm-2020-005
Khan K, Unar AA, Unar K, Rajper FQ, Baig MT. Evaluation of drug resistance and treatment outcomes among TB patients with diabetes mellitus in Sindh, Pakistan. J Pharm Res Int. 2021;33(27B):39–46.
DOI: https://doi.org/10.9734/jpri/2021/v33i27B31501
Ahmad Mughal M, Imran A, Khan HU, Farooq M, Ikram A, Arshad F, et al. Prevalence of multidrug-resistant tuberculosis and its association with previous treatment history in adults. Cureus. 2025;17(7):e88204.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Bhawani Shankar, Atif Ahmed Patoli, Bushra Bano Patoli, Iram Nabi Begum
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
